1-3
2026
影响因子区间
113天
平台估算
28%
2025
中国作者发文占比
—
收费
期刊简介:The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports. The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal’s scope. Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below:Discovery of new antibiotics and related types of biologically active substancesProduction, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substancesBiosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substancesNovel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substancesNewly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances.
【译文】《抗生素杂志》致力于促进抗生素及相关生物活性物质的研究,并发表文章、综述文章、简报、信件和其他特别委托的报告。该杂志接受有关生化、化学、微生物学和药理学研究的论文。然而,关于人类治疗的研究不属于该杂志的范围。特别鼓励关于最近发现的抗生素和生物活性微生物产品的贡献。该杂志特别感兴趣的主题包括但不限于以下内容:新抗生素及相关生物活性物质的发现生产、分离、表征、结构阐明、化学合成和衍生物、生物活性、作用机制和结构-活性关系抗生素及相关生物活性物质的生产微生物的生物合成、生物转化、分类学和遗传学研究,以及抗生素及相关生物活性物质生产的改进新型物理、化学、生化、微生物学或药理学方法用于检测、测定、结构阐明和评估抗生素及相关生物活性物质新发现的特性、作用机制和抗生素及相关生物活性物质的耐药性发展。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |